Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Early somatropin to improve left ventricular remodeling after acute myocardial infarction
2009-014431-20Phase 3Active
- Sponsor
- Andrés �ñiguez Romo
- Start
- Aug 2009
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial in myocardial infarction (MI) comparing Somatropin with Placebo (2 arms). Primary endpoints: Reduction in necrotic myocardial volume and Favorable left ventricular remodeling. Started Aug 2009; status: active.
02
Drugs
somatropin
03
Conditions
myocardial infarction (MI)
Beyond the preview
Go deeper on 2009-014431-20.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-014431-20.